Inflammatory mediators and stroke: new opportunities for novel therapeutics

FC Barone, GZ Feuerstein - Journal of Cerebral Blood Flow …, 1999 - journals.sagepub.com
Contrary to previous dogmas, it is now well established that brain cells can produce
cytokines and chemokines, and can express adhesion molecules that enable an in situ …

The neurotoxicity of environmental aluminum is still an issue

SC Bondy - Neurotoxicology, 2010 - Elsevier
Evidence for the neurotoxicity of extended exposure to low levels of aluminum salts is
described using an animal model treated with aluminum at low levels reflecting those found …

Double-knockout mice for α-and β-synucleins: effect on synaptic functions

S Chandra, F Fornai, HB Kwon… - Proceedings of the …, 2004 - National Acad Sciences
An abundant presynaptic protein, α-synuclein, is centrally involved in the pathogenesis of
Parkinson's disease. However, conflicting data exist about the normal function of α …

DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling

AL Northcutt, MR Hutchinson, X Wang, MV Baratta… - Molecular …, 2015 - nature.com
The initial reinforcing properties of drugs of abuse, such as cocaine, are largely attributed to
their ability to activate the mesolimbic dopamine system. Resulting increases in extracellular …

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

B Mirza, H Hadberg, P Thomsen, T Moos - Neuroscience, 1999 - Elsevier
Virtually any neurological disorder leads to activation of resident microglia and invasion of
blood-borne macrophages, which are accompanied by an increase in number and change …

WIN55, 212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine mouse model of …

DA Price, AA Martinez, A Seillier… - European Journal of …, 2009 - Wiley Online Library
Parkinson's disease (PD) is characterized by the progressive loss of nigrostriatal dopamine
neurons leading to motor disturbances and cognitive impairment. Current …

Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease

F L'Episcopo, C Tirolo, N Testa, S Caniglia… - Neurobiology of …, 2011 - Elsevier
Emerging evidence points to reactive glia as a pivotal factor in Parkinson's disease (PD) and
1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-lesioned mouse model of basal …

Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout

N Giguère, B Delignat-Lavaud, F Herborg… - PLoS …, 2019 - journals.plos.org
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of
dopamine (DA) neurons in the substantia nigra pars compacta (SNc). Rare genetic …

Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration

MC Morale, PA Serra, F L'Episcopo, C Tirolo… - Neuroscience, 2006 - Elsevier
Post-menopausal estrogen deficiency is recognized to play a pivotal role in the
pathogenesis of a number of age-related diseases in women, such as osteoporosis …

Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity

MJ LaVoie, JP Card, TG Hastings - Experimental neurology, 2004 - Elsevier
Previous studies have demonstrated methamphetamine (METH)-induced toxicity to
dopaminergic and serotonergic axons in rat striatum. Although several studies have …